Tin tức & Cập nhật
Xem bài viết Dược
Xem

Subcutaneous on par with IV pembrolizumab for NSCLC
Pembrolizumab administered subcutaneously (SC) is noninferior to the intravenous (IV) strategy in terms of overall exposure and trough concentrations, with similar efficacy and consistent safety profiles in patients with treatment-naive metastatic nonsmall cell lung cancer (NSCLC), reports a study.

Ecnoglutide trims weight in adults with obesity
Once-a-week treatment with ecnoglutide demonstrates superiority over placebo, with sustained reductions in body weight and improvements in cardiometabolic indexes among adults with overweight or obesity, reports a study presented at ADA 2025.

Which drugs benefit COVID-19 patients?
A systematic review and network meta-analysis of existing drug treatments for mild to moderate COVID-19 reveals that nirmatrelvir-ritonavir and remdesivir can possibly reduce hospital admissions, while corticosteroids and molnupiravir show potential in lowering hospitalizations.






